Author:
Fermini Bernard,Fossa Anthony A.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference39 articles.
1. Roden, D. M. & Balser, J. R. A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology. Cardiovasc. Res. 44, 242–246 (1999).
2. Antzelevitch, C. & Shimizu, W. Cellular mechanisms underlying the long QT syndrome. Curr. Opin. Cardiol. 17, 43–61 (2002).
3. Woosley, R. L. Drugs that prolong the QT interval and/or induce torsades de pointes [online], (cited 17 December 2002), <
http://www.qtdrugs.org/medical-pros/drug-lists/drug-lists.Htm
> (2002).
4. Dmitrienko, A. A. et al. Electrocardiogram reference ranges for Lilly clinical trials. Eli Lilly and Company, March 2002.
5. Linquist, M. & Edwards, R. Risks of non-sedating antihistamines. Lancet 349, 1322 (1997).
Cited by
441 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献